NEW YORK (GenomeWeb News) - Rosetta Genomics has licensed from the Max Planck Society rights to patents covering “potentially hundreds” of human microRNA sequences for use in diagnostic applications, the company said.
 
Rosetta said it will add the sequences to its microRNA database, where they will provide the company with additional biomarker candidates for its diagnostic-development programs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.